Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (311-320 of 491) with videos related to

Pageof 50
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2014
Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3Mattias Mandorfer, Berit A Payer, Philipp Schwabl, et al.
United European Gastroenterology Journal|December 21, 2024
Inflammation remains a dynamic component of portal hypertension in regressive alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Philipp Königshofer, et al.
Infection|October 21, 2015
Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcomeChristoph Boesecke, Patrick Ingiliz, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2024
Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' ReplyLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Journal of Hepatology|September 23, 2022
Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosisAlberto Zanetto, Filippo Pelizzaro, Elena Campello, et al.
Hepatology Communications|September 14, 2023
Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapyBernhard Scheiner, Katharina Lampichler, Katharina Pomej, et al.
Hepatology International|August 21, 2023
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcomeBenedikt Simbrunner, Ida Falk Villesen, Bernhard Scheiner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 13, 2026
Reliability of Hepatic Steatosis Quantification by Controlled Attenuation Parameter in Steatotic Liver DiseaseLucie Simonis, Yannick Marcour, Jan Embacher, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2024
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortalityLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
JHEP Reports : Innovation in Hepatology|March 24, 2025
Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosisAndrea Kornfehl, Anja Tiede, Paul Hemetsberger, et al.
Pageof 50

Showing results (311-320 of 491) with videos related to

Sort By:
Pageof 50
Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2014
Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3Mattias Mandorfer, Berit A Payer, Philipp Schwabl, et al.
United European Gastroenterology Journal|December 21, 2024
Inflammation remains a dynamic component of portal hypertension in regressive alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Philipp Königshofer, et al.
Infection|October 21, 2015
Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcomeChristoph Boesecke, Patrick Ingiliz, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2024
Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' ReplyLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Journal of Hepatology|September 23, 2022
Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosisAlberto Zanetto, Filippo Pelizzaro, Elena Campello, et al.
Hepatology Communications|September 14, 2023
Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapyBernhard Scheiner, Katharina Lampichler, Katharina Pomej, et al.
Hepatology International|August 21, 2023
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcomeBenedikt Simbrunner, Ida Falk Villesen, Bernhard Scheiner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 13, 2026
Reliability of Hepatic Steatosis Quantification by Controlled Attenuation Parameter in Steatotic Liver DiseaseLucie Simonis, Yannick Marcour, Jan Embacher, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2024
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortalityLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
JHEP Reports : Innovation in Hepatology|March 24, 2025
Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosisAndrea Kornfehl, Anja Tiede, Paul Hemetsberger, et al.
Pageof 50